Hepion Pharms Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,048 | 13,923 | 14,864 | 17,149 | 1,683 |
| TOTAL | $17,308 | $14,389 | $15,185 | $17,389 | $1,913 |
| Non-Current Assets | |||||
| PPE Net | 48 | 57 | 58 | 65 | 66 |
| Intangibles | 1,871 | 1,871 | 1,871 | 1,871 | 1,871 |
| Other Non-Current Assets | 4,043 | 4,295 | 3,960 | 4,015 | 4,055 |
| TOTAL | $5,963 | $6,223 | $5,889 | $5,950 | $5,991 |
| Total Assets | $23,270 | $20,612 | $21,074 | $23,339 | $7,905 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 330 | 790 | 1,903 |
| Accounts payable and accrued liabilities | 850 | 492 | 676 | 283 | 707 |
| Accrued Expenses | 413 | 851 | 308 | 535 | 657 |
| TOTAL | $1,536 | $1,610 | $1,505 | $1,798 | $3,457 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,948 | 2,976 | 2,981 | 3,151 | 3,442 |
| TOTAL | $2,966 | $3,385 | $3,342 | $3,512 | $3,803 |
| Total Liabilities | $4,502 | $4,995 | $4,847 | $5,310 | $7,259 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9 | 9 | 3 | 3 | 1 |
| Common Shares | 1 | 0 | 0 | 0 | 2 |
| Retained earnings | -87,409 | -83,752 | -81,288 | -79,469 | -78,448 |
| Other shareholders' equity | 856 | 856 | 856 | 856 | 1,764 |
| TOTAL | $18,768 | $15,617 | $16,227 | $18,029 | $646 |
| Total Liabilities And Equity | $23,270 | $20,612 | $21,074 | $23,339 | $7,905 |